Table 2.

Postoperative data at 12-month follow-up

Parameter	Hydrophilic Mean ± SD	Hydrophobic Mean ± SD	P value
UDVA at 12 mo (logMAR)	0.09 ± 0.14	0.16 ± 0.19	.06
CDVA at 12 mo (logMAR)	−0.03 ± 0.10	−0.02 ± 0.11	.53
SE at 12 mo	−0.32 ± 0.43	−0.36 ± 0.57	.73
SE within 0.50 D of target SE at 12 mo (%)	84.21	77.78	.58
SE within 1.00 D of target SE at 12 mo (%)	97.37	100	.46
ECC (preop vs 1 mo)	−360.10 ± 384	−225.40 ± 285.70	.11
Change in CatPROM-5^a (preop vs 12 mo)	−4.27 ± 2.74	−5.32 ± 2.81	.13
Change in EQ5D3L^a (preop vs 12 mo)	+0.06 ± 0.23	+0.03 ± 0.22	.66
Change in EQ5D3L raw score (preop vs 12 mo)	+7.53 ± 16.70	+4.60 ± 17.67	.48
Nd:YAG capsulotomy for PCO by 12 mo (n)	0	0	1.00
PCO grading at 1 mo	2.05 ± 1.30	2.53 ± 1.59	.18
PCO grading at 6 mo	1.92 ± 1.02	2.49 ± 2.43	.22
PCO grading at 12 mo	3.64 ± 4.33	3.83 ± 4.51	.86

ECC = endothelial cell count; PCO = posterior capsular opacification

Calibrated score